Strong Quarterly Results Lifted Merit Medical Systems (MMSI) in Q1

1 month ago 11

Soumya Eswaran

Tue, Apr 29, 2025, 7:03 AM 3 min read

Conestoga Capital Advisors, an plus absorption company, released its first-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. Equity markets started the twelvemonth with a rally owed to optimism astir a beardown system and expectations of moderating ostentation and little involvement rates. However, concerns implicit slowing net from large Technology companies, geopolitical tensions, and an upcoming announcement connected tariffs led to a crisp diminution successful equities by the extremity of the archetypal quarter. Investors sought safety, driving U.S. Treasury yields down. The Conestoga Small Cap Composite returned -11.35% (net) successful the archetypal 4th compared to the Russell 2000 Growth Index’s -11.12% return. The Conestoga SMid Cap Composite returned -5.73% compared to the Russell 2500 Growth Index’s -10.80% return. The Conestoga Micro-Cap Composite returned -8.24% vs the Russell Microcap Growth Index’s instrumentality of -17.75%. Finally, the Conestoga Mid Cap Composite returned 0.96% (net), compared to the Russell Midcap Growth Index’s -7.12% return. Please cheque the apical 5 holdings of the money for a amended knowing of their champion picks for 2025.

In its first-quarter 2025 capitalist letter, Conestoga Capital Advisors highlighted stocks specified arsenic Merit Medical Systems, Inc. (NASDAQ:MMSI). Merit Medical Systems, Inc. (NASDAQ:MMSI) designs, develops, manufactures, and markets single-use aesculapian products. The one-month instrumentality of Merit Medical Systems, Inc. (NASDAQ:MMSI) was -9.72%, and its shares gained 27.10% of their worth implicit the past 52 weeks. On April 28, 2025, Merit Medical Systems, Inc. (NASDAQ:MMSI) banal closed astatine $95.44 per stock with a marketplace capitalization of $5.64 billion.

Conestoga Capital Advisors stated the pursuing regarding Merit Medical Systems, Inc. (NASDAQ:MMSI) successful its Q1 2025 capitalist letter:

"Merit Medical Systems, Inc. (NASDAQ:MMSI) delivered beardown quarterly results, exceeding expectations for some income and net growth. The company's vertically integrated concern exemplary continued to supply manufacturing stableness and competitory vantage successful some cardiovascular and endoscopy segments. Its OEM conception continued to resonate with customers’ persistent proviso concatenation challenges successful the industry. Gross and operating margins showed accordant improvement, positioning MMSI good to execute its agelong word targets. We judge caller merchandise launches on with strategical acquisitions heighten MMSI's presumption successful higher-growth therapeutic markets."